Table 3 Multivariate regression analysis of factors associated with HIV antiretroviral therapy
| Â | Adjusted OR (95% CI) | P-value |
|---|---|---|
Age | 1.012 (0.998, 1.025) | 0.1024 |
Gender | Â | Â |
 Female | 1 | - |
 Male | 1.306 (0.823, 2.073) | 0.2571 |
Race | Â | Â |
 White, non Hispanic | 1 | - |
 African-American, non Hispanic | 0.682 (0.500, 0.932) | 0.4559 |
 Hispanic | 0.795 (0.486, 1.301) | 0.9695 |
 Other | 0.759 (0.211, 2.725) | 0.9097 |
Region | Â | Â |
 Northeast | 1 | - |
 Midwest | 1.271 (0.545, 2.966) | 0.211 |
 West | 0.442 (0.137, 1.421) | 0.098 |
 South | 1.148 (0.589, 2.238) | 0.2706 |
Insurance | Â | Â |
 Private Insurance | 1 | - |
 Medicare | 0.87 (0.588, 1.286) | 0.1827 |
 Medicaid | 0.547 (0.298, 1.005) | 0.0526 |
 Unknown/other | 0.602 (0.324, 1.119) | 0.0531 |
 Self-pay | 0.521 (0.216, 1.258) | 0.1352 |
 No Charge | 0.629 (0.398, 0.996) | 0.0437 |
HIV/HCV Coinfection vs. HIV Monoinfection | Â | Â |
 2005-2006 (year of visit) | 2.533 (1.618, 3.965) | <.0001 |
 2007-2008 (year of visit) | 7.464 (1.9, 29.317) | 0.004 |
 2009-2010 (year of visit) | 2.888 (1.364, 6.117) | 0.0056 |